GT Biopharma Cash from Investing (TTM) Analysis

GT Biopharma Inc (GTBP)

3.30 +0.10 (+3.29%) USD | NASDAQ | May 03, 16:00

3.30 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 1992. Upgrade now.

Date	Value
December 31, 2023	-2.009M
September 30, 2023	5.019M
June 30, 2023	3.199M
March 31, 2023	1.623M
December 31, 2022	12.14M
September 30, 2022	7.63M
June 30, 2022	-18.43M
March 31, 2022	-19.51M
December 31, 2021	-23.04M
September 30, 2021	-26.03M
June 30, 2021	0.00
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018	-0.036M
September 30, 2018	-0.008M
June 30, 2018	-0.006M
March 31, 2018	-0.006M
December 31, 2017	-0.004M

Date	Value
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014	0.00
December 31, 2013	0.00
September 30, 2013	-0.002M
June 30, 2013	-0.002M
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-26.03M

Minimum

Sep 2021

12.14M

Maximum

Dec 2022

-5.400M

Average

Median

Jun 2021

Cash from Investing (TTM) Benchmarks